Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension

NCT05968430 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1076

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: lorundrostat
DRUG: Placebo

Sponsor

Mineralys Therapeutics Inc.